Delivery Order SPE2DB20D9214-SPE2DB25FD4ZC
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $16,249.95 from the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, issued without set-aside designation, covers the supply of Stelara 90 mg/mL syringes to support military healthcare operations. This award represents a single task order executed under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on June 3, 2025. The delivery order, which carries an ultimate completion date of June 25, 2025, covers the supply of Stelara 90 mg/ml syringes for distribution to military healthcare facilities. This award was issued without a set-aside designation, allowing the vendor to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on July 18, 2025. The delivery order, which must be completed by August 8, 2025, is for Stelara 90 mg/mL syringes and was issued without a set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 10, 2025, for Stelara 90 mg/ml syringes. The contract ceiling value is $32,499.90, with an ultimate completion date of October 1, 2025. This delivery order was issued without a set-aside designation, demonstrating the company's competitive positioning in federal pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,154.36 by the Defense Logistics Agency (DLA) on September 18, 2025. The order is for Stelara 90 mg/ml syringes, a biologic medication commonly used to treat inflammatory conditions. This delivery order was issued without a set-aside designation and operates under a firm fixed-price structure, with an ultimate completion date of October 9,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, which will be completed by September 3, 2025, covers the supply of Stelara 90 mg/mL syringes, a biologic medication used to treat autoimmune conditions. This award carries no set-aside designation and represents a direct transaction under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $97,499.70 by the Defense Logistics Agency (DLA) on August 8, 2025. This firm fixed-price delivery order is for the supply of Stelara 90 mg/ml syringes, with an ultimate completion date of August 29, 2025. The contract utilizes no set-aside designation, demonstrating the company's competitive positioning in federal procurement markets. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on September 12, 2025. This delivery order, without set-aside designation, calls for the supply of Stelara 90 mg/ml syringes to support Department of Defense healthcare requirements. The award is expected to be completed by October 3, 2025, with performance taking place at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $97.5K firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Stelara 90 mg/mL syringes. The contract carries an ultimate completion date of October 2, 2025, and includes no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on September 9, 2025. The delivery order is for Stelara 90 mg/mL syringes, a biologic medication used to treat autoimmune conditions. This award was issued without a set-aside designation and carries an ultimate completion date of September 30, 2025, with performance to be...
- SPE2DB20D9214Indefinite Delivery Contract
- SPE2DB20D9214-SPE2DB25FD4ZCDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 29, 2025, valued at $16,154.36. The delivery order, which has an ultimate completion date of October 21, 2025, is for Stelara 90 mg/ml syringes. This award was issued without a set-aside designation, allowing the contractor to compete directly in the open federal marketplace. The performance location is the contractor's facility in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a comprehensive pharmaceutical supply agreement valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to procure a broad range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its extensive contract portfolio with DLA to provide essential medications and medical supplies to military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 9/29/25 |